<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk factors for hemodialysis arteriovenous fistula failure</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk factors for hemodialysis arteriovenous fistula failure</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Risk factors for hemodialysis arteriovenous fistula failure</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gerald A Beathard, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ellen D Dillavou, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2129737409"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Evaluation of the end-stage kidney disease (ESKD) patient in preparation for the placement of a hemodialysis access is extremely important. Proper patient selection enhances the opportunity to place the access most appropriate for the individual patient. This evaluation should be detailed and complete. (See  <a class="medical medical_review" href="/z/d/html/110008.html" rel="external">"Patient evaluation prior to placement of hemodialysis arteriovenous access"</a>.)</p><p>Each predialysis and dialysis patient should have an individualized ESKD Life-Plan [<a href="#rid1">1</a>], which should start in the predialysis period if possible, with the goal of maximizing ESKD dialysis modality choices and utilization for a specific patient's foreseeable lifespan. In developing this plan, risk factors having a potential adverse effect on the success of the dialysis access must be taken into consideration.</p><p>Many patients have more than one risk factor because they have multiple comorbidities. The dialysis patient population is among the sickest with a symptom burden comparable to that of the cancer patient [<a href="#rid2">2,3</a>]. Older patients represent the most rapidly growing group of dialysis patients, and approximately one half of ESKD patients over 75 years of age have three or more comorbidities [<a href="#rid4">4</a>].</p><p>Definitions for the hemodialysis access time points used in this topic (eg, primary patency, assisted primary patency, postintervention patency) are provided in the figure  (<a class="graphic graphic_figure graphicRef115040" href="/z/d/graphic/115040.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef70111" href="/z/d/graphic/70111.html" rel="external">table 1</a>).</p><p>Although this discussion is directed primarily toward factors that create a risk for failure of arteriovenous (AV) fistula development, it should be realized that some of these factors also represent a risk to the patient's well-being (life and limb). </p><p>The risk factors associated with failure of hemodialysis AV fistula maturation and failure of a mature AV fistula are reviewed here. The choice of hemodialysis AV access and placement and care of the AV fistula are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1917.html" rel="external">"Arteriovenous fistula creation for hemodialysis and its complications"</a> and  <a class="medical medical_review" href="/z/d/html/112108.html" rel="external">"Overview of hemodialysis arteriovenous fistula maintenance and thrombosis prevention"</a> and  <a class="medical medical_review" href="/z/d/html/115151.html" rel="external">"Approach to the adult patient needing vascular access for chronic hemodialysis"</a>.)</p><p class="headingAnchor" id="H2750062341"><span class="h1">USE OF RISK FACTORS</span><span class="headingEndMark"> — </span>Although risk factors are important, risk stratification schemes based on demographic and clinical parameters fail to accurately identify individuals in whom arteriovenous (AV) fistula placement is futile. The identification of a high-risk patient simply dictates the need for more intensive, individualized evaluation [<a href="#rid5">5</a>]. The most important determinant in the success of an AV fistula is the quality of the available vessels (ie, hemodynamic factors). Individualization based upon preprocedural vascular mapping is critical. No patient with end-stage kidney disease (ESKD) should be excluded from consideration for an AV fistula without vascular mapping and evaluation by an experienced hemodialysis access vascular surgeon. (See  <a class="medical medical_review" href="/z/d/html/110008.html" rel="external">"Patient evaluation prior to placement of hemodialysis arteriovenous access"</a>.)</p><p>While the goal of patient evaluation prior to access placement is to facilitate the placement of an AV fistula, failure of AV fistula maturation remains a major problem with serious clinical consequences, not least of which is prolonging the period of catheter dependency. Thus, the patient with a low likelihood of AV fistula maturation based upon an individualized evaluation might be better served by placement of an AV graft. (See  <a class="medical medical_review" href="/z/d/html/115151.html" rel="external">"Approach to the adult patient needing vascular access for chronic hemodialysis", section on 'Strategy for lifelong hemodialysis access'</a>.)</p><p class="headingAnchor" id="H4055174970"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>The risk of poor arteriovenous (AV) fistula maturation or subsequent AV fistula failure can be regarded as related to either hemodynamic factors, patient-related demographic or clinical factors, or other technical issues. Among these, hemodynamic factors are the most important. Demographic and clinical risk factors are generally realized only when they affect hemodynamics. </p><p class="bulletIndent1"><span class="glyph">●</span>Hemodynamic – Vein size, feeding artery size, blood flow</p><p class="bulletIndent1"><span class="glyph">●</span>Demographic – Patient age, sex, race/ethnicity</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical – The presence of cardiac disease, peripheral arterial disease, pulmonary hypertension, diabetes mellitus, obesity </p><p class="bulletIndent1"><span class="glyph">●</span>Technical – Training and experience of surgeon, fistula creation, care and use of the AV fistula</p><p></p><p class="headingAnchor" id="H2863155179"><span class="h2">Hemodynamic</span><span class="headingEndMark"> — </span>The value of vascular mapping in assessing hemodynamic parameters has been well documented in the literature. (See  <a class="medical medical_review" href="/z/d/html/110008.html" rel="external">"Patient evaluation prior to placement of hemodialysis arteriovenous access"</a> and  <a class="medical medical_review" href="/z/d/html/1917.html" rel="external">"Arteriovenous fistula creation for hemodialysis and its complications"</a>.) </p><p>Patients with inadequate size or quality of vessels may not be candidates for an AV fistula, at least initially. In these cases, the creation of an AV access in the forearm using graft material may be the best option. The purpose is twofold. The AV graft will provide a useable dialysis access, and the veins in the upper arm may develop over time such that a secondary AV fistula may be possible, if the AV graft becomes problematic [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/1835.html" rel="external">"Hemodialysis access following a failed arteriovenous access"</a>.)</p><p class="headingAnchor" id="H3277665022"><span class="h2">Demographic</span><span class="headingEndMark"> — </span>Demographic factors include age, sex, and race/ethnicity. Demographic and clinical risks are generally realized only when they affect hemodynamics. </p><p class="headingAnchor" id="H2610221167"><span class="h3">Age</span><span class="headingEndMark"> — </span>Since the older patient represents the fastest growing group of end-stage kidney disease (ESKD) patients, age is an increasingly important factor to consider when planning hemodialysis vascular access. Renal failure behaves differently in older compared with younger adults [<a href="#rid7">7</a>]. Older patients lose renal function at a slower rate than is typical for younger patients, and fewer progress to ESKD requiring dialysis. However, older age is a risk factor for decreased life expectancy on dialysis [<a href="#rid8">8</a>]. However, it is the presence of comorbidities that appears to have a stronger effect on survival, rather than incremental age alone [<a href="#rid9">9,10</a>]. Rather than being a risk factor itself, advancing age largely acts as a surrogate for an increasing incidence of comorbidity that comes with age, particularly for diabetes and cardiovascular disease. Overall, age as an isolated variable should not greatly affect access decisions other than considerations related to the expected age-related longevity of the individual patient. As an example, there may be a concern that an older patient may die in the time interval between AV fistula creation and the initiation of dialysis [<a href="#rid11">11,12</a>].</p><p>A problem in analyzing published data related to age is the variability of the age groups being studied. In a meta-analysis involving 13 studies of dialysis access outcomes, the most commonly used age for the "older patient" category was &gt;65 years [<a href="#rid13">13</a>]. However, age &gt;75 years is associated with the highest incidence rate of ESKD (per million/year), with those 65 to 74 years having the second highest incidence [<a href="#rid14">14</a>]. Defining older age as a homogeneous group &gt;65 years leads to skewed results. </p><p>The increased burden of comorbidity in the older patient may materially affect patient selection for AV fistula creation; however, once an AV fistula is established in these cases, patency appears to be comparable to that of younger age groups. This is illustrated by three points based upon 2016 United States Renal Data System (USRDS) data [<a href="#rid14">14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>AV fistula time to maturation did not differ significantly between age groups. The average intervals of time from AV fistula placement to first use for age categories 22 to 44, 45 to 64, 65 to 74, and &lt;75 years were 129, 132, 136, and 133 days, respectively. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AV fistula use did not differ significantly between age groups. AV fistula use at 3 and 12 months by these age categories (22 to 44, 45 to 64, 65 to 74, and &lt;75 years) was 22 and 63, 25 and 67, 27 and 65, and 24 and 60 percent, respectively. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AV fistula primary failure rates differed only modestly between age groups. The AV fistula failure rates for age categories 22 to 44, 45 to 64, 65 to 74, and &gt;75 years were 32, 34, 37, and 40 percent, respectively. </p><p></p><p>There is a general lack of concordance in the literature concerning the effect of age on AV fistula development and patency. There are studies showing that age has an overall negative effect [<a href="#rid15">15</a>], that primary patency is poorer but cumulative patency is equal [<a href="#rid16">16</a>], and that there is no age-related difference in AV fistula success [<a href="#rid17">17</a>]. The reasons for inconsistency are multiple. A major issue is that most studies have lumped all patients beyond a certain age into the same "older patient" category. In addition, all patients go through a selection process for the creation of an AV fistula, and due to the increasing comorbidity burden with age, the selection process is probably more rigorous for the older patient. There are also significant differences between individual surgeons and surgical programs that can make a difference [<a href="#rid18">18</a>]. Unfortunately, there are no randomized trials to provide a more definitive answer. However, the fact that there are studies showing that age is not a negative factor for AV fistula development indicates what can be accomplished with vascular mapping and individual patient evaluation of risk factors [<a href="#rid19">19</a>]. It should be noted that in some studies in which age over 65 was associated with increased risk of primary failure, preprocedure vascular mapping was not routinely performed [<a href="#rid16">16</a>].</p><p>In a study of 461 patients ranging in age from 65 to 94 (mean age 73 years) in whom vascular mapping was performed, primary, assisted primary, and cumulative patencies were 60, 94, and 97 percent at 12 months and 45, 90, and 95 percent at 24 months, respectively, with a mean follow-up of 17 months [<a href="#rid17">17</a>]. When the patients were stratified by age into 65 to 74, 75 to 84, and 85 to 94 year groups, there were no significant differences in AV fistula outcomes. In addition, a comparison of primary, assisted primary, and cumulative patency rates for all older (≥65 years) compared with all younger (&lt;65 years) patients also showed no difference.</p><p>In another study of 525 patients who were followed for three years after AV fistula creation based upon vascular mapping, there were no significant differences for failure to mature or primary patency rates at one, two, and three years between groups stratified by age (&lt;65, 65 to 75, and &gt;75 years) [<a href="#rid19">19</a>]. However, age &gt;75 years was associated with worse cumulative patency (hazard ratio [HR] 1.90, 95% CI 1.15-3.14).</p><p>An integral part of the patient's ESKD Life-Plan is the adoption of an anatomical progression in access planning that allows for maximum conservation of more proximal vessels. Classically, the order preference to accomplish this goal is to start distally with a radial-cephalic AV fistula, if possible. Studies that suggest that for the older patient this approach may not be appropriate [<a href="#rid13">13,20</a>]. As with AV fistulas in general, published studies using age as a factor in the analysis of access outcome and survival have yielded conflicting results and conclusions. However, studies using preprocedure vascular mapping and individualized patient selection have shown comparable results for radial-cephalic AV fistulas regardless of age.</p><p>In a review involving 361 patients with a radial-cephalic AV fistula and 297 with a brachial-cephalic AV fistula, primary and cumulative patencies were compared by age group: &lt;65, 65 to 79, and &gt;80 years of age [<a href="#rid21">21</a>]. The distribution of patients in these three groups was 43.8, 41.6, and 14.6 percent, respectively. Only 85.7 percent of patients progressed to hemodialysis. Primary patency for radial-cephalic AV fistulas at one and two years was 46.0 and 27.1 percent for the &lt;65 year group, 47.0 and 36.0 percent for the 65 to 79 year group, and 45.7 and 38.1 percent for the &gt;80 year group, respectively. Radial-cephalic AV fistula cumulative patency rates at one and two years were 46.1 and 27.8 percent for the &lt;65 year group, 47.8 and 37.5 percent for 65 to 79 year group, and 47.8 and 39.9 percent for the &gt;80 year group. These differences were not statistically significant. </p><p>Primary patency rates at one and two years for the brachial-cephalic AV fistula in this same study were 39.3 and 31.0 percent, 53.3 and 37.5 percent, and 46.3 and 42.6 percent for the same age groups and time intervals, respectively [<a href="#rid21">21</a>]. The brachial-cephalic AV fistula cumulative patency rates at one and two years were 41.0 and 33.6 percent for the &lt;65 year group, 55.7 and 39.2 percent for the 65 to 79 year group, and 46.3 and 42.6 percent for the &gt;80 year group (p = 0.25). In addition, there was no significant difference between age groups for the radial-cephalic versus the brachial-cephalic AV fistula for either primary or cumulative patency. The authors of this report emphasized that with proper patient selection, older patients of all age groups can be considered suitable for either a radial-cephalic AV fistula or a brachial-cephalic AV fistula.</p><p class="headingAnchor" id="H2322929093"><span class="h3">Sex</span><span class="headingEndMark"> — </span>As with older age, sex also presents several unique features related to dialysis and vascular access. </p><p>Males have a higher level of kidney function compared with females at the same level of serum creatinine as a result of greater muscle mass and creatinine generation. This is important to recognize because referrals for vascular access at a fixed level of serum creatinine would systematically refer women with more advanced disease [<a href="#rid22">22</a>]. However, although there are some conflicting data, several studies have shown that the rate of renal deterioration is slower in women compared with men, and women have improved renal survival and lower overall mortality compared with men (104 versus 123 per 1000 patient-years at risk) [<a href="#rid14">14,22-27</a>]. </p><p>Although there are reports to the contrary [<a href="#rid28">28,29</a>], most investigations have found significant differences in outcomes of AV fistula creation when comparing males and females. In one study, females were at greater risk for failure of the AV fistula to mature compared with the males in spite of preoperative vascular mapping (hazard ratio 2.42, 95% CI 1.32-4.45) [<a href="#rid30">30</a>]. However, the 2016 USRDS data show a different picture [<a href="#rid14">14</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Females had a higher overall rate of AV fistula maturation compared with in males (41.6 versus 31.5 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>More males were using AV fistulas at the initiation of dialysis, 18.4 versus 14.8 percent in females. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The duration of patency was shorter for females compared with in males, with AV fistula use at 3 and 12 months of 26.2 and 55.9 percent versus 27.9 and 70.6 percent, respectively.</p><p></p><p>The reasons for these differences are not clear. It has been suggested that females have smaller vessels [<a href="#rid31">31</a>]; however, comparative studies of preoperative vascular mapping have not supported this premise. In one study involving 106 females and 86 males, no significant difference in vein size was observed at any of 17 sites that were examined [<a href="#rid32">32</a>]. However, arterial size was significantly smaller in females at 3 of 12 different sites that were measured. These sites were all in the distal forearm. In another study involving 84 females and 105 males with preoperative vascular mapping, no differences in vein diameters were noted between the sexes [<a href="#rid33">33</a>]. However, arterial differences were also noted. Arteries used for AV fistula construction were smaller in females in both forearm and upper arm placements, but in a comparison between successful and unsuccessful AV fistulas, there were no differences in either arterial or venous diameters in either the forearm or upper arm.</p><p class="headingAnchor" id="H1278209117"><span class="h3">Race/ethnicity</span><span class="headingEndMark"> — </span>While some studies show racial/ethnic differences in AV fistula use and failure rates, the reasons for the difference are not totally clear. While a genetic difference between different racial/ethnic groups cannot be totally discarded, there are definite differences in comorbidities between the groups [<a href="#rid14">14,34-37</a>]. These factors have the potential to affect the development of ESKD and the creation of an AV fistula for dialysis. </p><p>There is a higher rate of both type 2 diabetes and hypertension in Black compared with White Americans, and the risk of type 2 diabetes in Native Americans and Hispanic Americans is even higher [<a href="#rid38">38</a>]. As an example, from USRDS data, the incidence of obesity is higher in Black hemodialysis patients compared with non-Hispanic White patients [<a href="#rid39">39</a>]. This can adversely affect AV fistula creation but had a positive effect on patient longevity due to the "obesity paradox" (see <a class="local">'Obesity'</a> below). In addition, disparities in health care delivery in the US, including the use of preventive services, are well documented [<a href="#rid40">40</a>]. </p><p>Although not consistently reported, race has been listed as a risk factor for failure of AV fistula maturation in the United States and Canada [<a href="#rid5">5,41-44</a>], and racial/ethnic differences have been documented in AV fistula use in prevalent dialysis patients [<a href="#rid45">45</a>]. A US study was conducted using ESKD Medical Evidence Report data to determine the correlation between risk factors in AV fistula use in 195,756 adult patients initiating outpatient hemodialysis therapy who had six or more months of prior nephrology care [<a href="#rid45">45</a>]. The likelihood of Black American patients beginning outpatient hemodialysis therapy using an AV fistula was 60 percent lower compared with White Americans, and for Hispanic Americans, 10 percent lower compared with non-Hispanic Americans. Similarly, in a review of ESKD data for 2016, Black Americans were less likely to start dialysis using an AV fistula, using White Americans as the reference, as were Native Americans [<a href="#rid14">14</a>]. </p><p>Racial and ethnic differences in AV fistula failure rates were also evident in the 2016 United States Renal Data System (USRDS) data [<a href="#rid14">14</a>]. By ethnicity, the highest AV fistula failure rate occurred in non-Hispanic Americans, with a rate of 36.2 compared with 29.2 percent in Hispanic Americans. Within the non-Hispanic population, the highest failure rate occurred in Black Americans (38.2 percent), followed by White Americans (35.7 percent). Although the case numbers were small, the remaining failure rates were given as 33.9 percent for Native Americans, 30.3 percent for Asian Americans, and 27.3 percent for other non-Hispanic Americans.</p><p>AV fistula use at 12 months was also lowest in Black Americans at 58.5 percent, compared with a high of 75 percent in the Native American group, 66.9 percent in the white group, and 69.7 percent in the Asian group. AV fistula use in the total group of prevalent patients, those on dialysis for &gt;90 days, was lowest for the Black participants at 57.7 percent. The values for other groups were 68 percent for Hispanic Americans, 64.9 percent for White Americans, 75.1 percent for Native Americans, and 67.5 percent for Asian Americans.</p><p class="headingAnchor" id="H632530194"><span class="h2">Clinical comorbidities</span><span class="headingEndMark"> — </span>Clinical risk factors for AV fistula failure include the presence of cardiac disease, pulmonary disease, peripheral arterial disease, diabetes, and obesity. </p><p class="headingAnchor" id="H3145999175"><span class="h3">Cardiac disease</span><span class="headingEndMark"> — </span>Cardiovascular disease (CVD) is an important comorbidity among patients with CKD. In 2016, 68.8 percent of patients &gt;66 years of age with CKD had some form of CVD [<a href="#rid14">14</a>]. The prevalence of heart failure was 28.2 percent, and atrial fibrillation was present in 25.3 percent (nearly one half of patients with heart failure also had atrial fibrillation). In addition, CVD presents a mortality risk for the ESKD patient. Death from CVD is 10 to 20 times higher in these patients compared with in the general population [<a href="#rid46">46</a>].</p><p>The relationship between CVD and CKD is complex. The two share risk factors such as diabetes and hypertension. In addition, CKD is associated with changes that can increase the risk of developing CVD, such as abnormalities of mineral metabolism, anemia, volume overload, and CKD-associated vascular changes. CVD can also increase the risk of CKD [<a href="#rid47">47</a>]. In addition, all forms of CVD have an increased incidence in CKD patients. This close relationship should be given consideration in dialysis access planning. Classification during the predialysis period according to the severity of cardiac symptoms in one of four categories (New York Heart Association Functional class I to IV) can help guide the selection of the most appropriate hemodialysis access [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/z/d/html/1958.html" rel="external">"Evaluation and management of heart failure caused by hemodialysis arteriovenous access"</a>.)</p><p>The heart is a critical part of the dialysis access circuit, providing the driving force for blood flow necessary to meet the demands of the dialysis access. The creation of an AV fistula produces a hyperdynamic state that increases cardiac workload (volume-loaded state) and exerts significant effects on cardiac systolic and diastolic performance. Many of the early cardiac changes are physiological and adaptive; however, there are those that are maladaptive and deleterious to cardiac function and can lead to increased cardiac strain and poor subendocardial perfusion [<a href="#rid49">49</a>]. </p><p>For patients with relatively normal cardiac function, the creation of an AV fistula should not be expected to have adverse effects. Some reports have noted an improvement in cardiovascular function with the creation of an AV dialysis access [<a href="#rid50">50</a>]. However, poor cardiac function adversely affects blood flow to the developing AV fistula. In addition, by increasing demand for cardiac output, the AV fistula can adversely affect the heart. </p><p>ESKD patients with decreased cardiac reserve are at risk for developing heart failure after AV access construction while those with a history of heart failure are at risk for worsening their condition. The deleterious effect of an AV fistula on the heart is directly proportional to access blood flow [<a href="#rid51">51</a>]. Since flow rate is generally higher with a brachial artery-based AV fistula compared with a radial artery-based AV access, the increase in cardiac output will be proportionately more. In a prospective study involving 96 hemodialysis patients, 31 patients with an upper-arm AV fistula had a significantly higher mean flow rate, cardiac output, and flow rate to cardiac output ratio compared with 65 patients with a lower-arm AV fistula [<a href="#rid52">52</a>]. This difference was evident even in the early maturation period of AV fistula creation. In an observational study of 562 predialysis patients, the location of AV fistula was closely related to the incidence of heart failure (40 percent in brachial-cephalic versus 8 percent in radial-cephalic AV fistula) [<a href="#rid49">49</a>]. This suggests that in a patient with decreased cardiac function, if an AV fistula is created, a radial artery-based access with a lower flow rate would be desirable. </p><p class="headingAnchor" id="H2688858909"><span class="h3">Peripheral arterial disease</span><span class="headingEndMark"> — </span>To achieve a functional AV fistula, the feeding brachial artery must increase baseline blood flow 10- to 20-fold to deliver the required blood volume for the fistula, as well as to supply distal tissues [<a href="#rid53">53</a>]. To do this, the artery must increase diameter sufficiently by remodeling to accommodate the increased flow [<a href="#rid54">54</a>]. Peripheral arterial disease interferes with this process. In one study involving 784 incident hemodialysis patients, a history of peripheral artery disease was associated with a 24 percent higher risk of AV fistula failure [<a href="#rid55">55</a>]. </p><p>Peripheral arterial disease changes in the vessel wall are characterized by intimal hyperplasia and calcification. At a histologic level, the presence of calcium deposits within the vessel wall of radial and brachial arteries in patients with CKD has been correlated with increased arterial stiffness and decreased elasticity [<a href="#rid56">56</a>]. </p><p>In a study involving 59 patients in whom a radial-cephalic AV fistula was created, surgically obtained arterial specimens were examined for intimal hyperplasia, which was found in 45 cases [<a href="#rid57">57</a>]. Patients with intimal hyperplasia were older and had a higher incidence of diabetes. A strong correlation was seen between AV fistula failure and intimal hyperplasia. In another study involving 72 diabetic patients, macrocalcification (Mönckeberg type) in the vessel wall (determined radiologically) correlated with decreased long-term AV fistula patency [<a href="#rid58">58</a>]. It is of interest that in another publication, microcalcification (determined histologically) had no effect on AV fistula maturation [<a href="#rid59">59</a>]. </p><p>Tests directed toward detection of feeding artery pathology have been advocated (eg, resistive index, assessment of arterial stiffness and elasticity, hyperemic response) [<a href="#rid56">56</a>]. A number of studies have reported a positive correlation between poor results in these tests and AV fistula failure [<a href="#rid60">60-65</a>]. As an example, in a small study of patients undergoing AV fistula placement, the average radial artery elasticity index (ie, less stiffness) was higher in the group that developed a mature AV fistula compared with the group in whom the AV fistula failed; however, the brachial artery elasticity index was not significantly different in the success and failure groups. </p><p class="headingAnchor" id="H239147603"><span class="h3">Pulmonary hypertension</span><span class="headingEndMark"> — </span>Pulmonary hypertension is also an important comorbidity in those with CKD. Its presence can materially affect the life expectancy of the dialysis patient and influence dialysis access choices. (See  <a class="medical medical_review" href="/z/d/html/112442.html" rel="external">"Pulmonary hypertension in patients with end-stage kidney disease"</a>.)</p><p>A high incidence of pulmonary hypertension (PH) occurs in patients with CKD, where it is associated with an increased risk of cardiovascular events and overall mortality [<a href="#rid66">66-68</a>]. Although the highest level occurs in the dialysis patient, an increased incidence has been reported prior to the initiation of dialysis. In one study of 211 patients, an incidence of 21.6, 24.1, and 31.7 percent was reported in nondialysis patients with CKD stages 3, 4, and 5, respectively [<a href="#rid69">69</a>]. </p><p>Although not directly related to renal disease, chronic obstructive pulmonary disease (COPD) is a significant cause of mortality in the population at large; this is no less so for the patient with ESKD. In 2013, the overall incidence in the United States was 6.4 percent [<a href="#rid70">70</a>]. In the years 2000 to 2010, the prevalence of COPD in the patient age group 60 to 79 years (the fastest-growing ESKD age group) was 13.5 percent [<a href="#rid71">71,72</a>].</p><p class="headingAnchor" id="H3477706283"><span class="h3">Diabetes mellitus</span><span class="headingEndMark"> — </span>Although diabetes mellitus is generally listed as a risk factor for AV fistula failure, the diabetic state does not exert a direct adverse effect on the success of the access; however, the comorbidities associated with diabetes do have definite effect. As was the case with advanced age, diabetes serves as a surrogate for other comorbidities. Individuals with diabetes have a high risk for developing cardiovascular disease, including peripheral arterial disease [<a href="#rid73">73</a>]. The relationship is even greater in patients with CKD [<a href="#rid14">14</a>]. There is also an interplay between other clinical and demographic risk factors. (See <a class="local">'Race/ethnicity'</a> above.)</p><p>Since it is not diabetes as such but the associated burden of comorbidities that exerts the effect, pre-access clinical and hemodynamic evaluation can make a marked difference in achieving success with AV fistula creation. While some reports indicate a negative effect of diabetes on AV fistula success [<a href="#rid74">74-76</a>], most investigators have reported that diabetes is not significantly associated with primary AV fistula failure and that the success rate of a forearm AV fistula is comparable in patients with and without diabetes [<a href="#rid59">59,77-80</a>]. </p><p class="headingAnchor" id="H1841892746"><span class="h3">Obesity</span><span class="headingEndMark"> — </span>Two issues are of importance when considering the creation of an AV fistula in the obese patient. First, obesity is a major risk factor for the development of type 2 diabetes. Therefore, these patients frequently present with the same issues as discussed for the patient with diabetes (see <a class="local">'Diabetes mellitus'</a> above). The second is the technical issue related to the depth of the vessels used to create the fistula. An added consideration is the obesity paradox (ie, higher body mass index [BMI] is paradoxically associated with better survival among renal failure patients) [<a href="#rid81">81-83</a>]. This, in addition to the fact that patients with severe obesity may be excluded from transplant consideration, means that their accesses must last longer than those of other patients. </p><p>When presented with a patient with obesity, there is no reason to avoid the creation of an AV fistula, but evaluation of hemodynamic factors by vascular mapping becomes particularly important. A retrospective cohort analysis was performed using the USRDS Dialysis Morbidity and Mortality Wave II data set to evaluate the relationships between obesity and vascular access outcomes [<a href="#rid84">84</a>]. Obesity was associated only with poorer AV fistula maturity at the highest BMI quartile (≥35 kg/m<sup>2</sup>) and not with increased AV fistula revision rates or failure. However, although the likelihood of fistula placement and primary patency rates were similar across groups, secondary patency was significantly lower in patients with obesity [<a href="#rid85">85</a>]. It has been suggested that the decreased secondary patency in these patients could be due to soft tissue compression of the venous outflow of the upper extremity in the adducted position [<a href="#rid86">86</a>]. </p><p>In addition, a technical problem can occur in patients with obesity related to the depth of the veins, which tend to be deep due to the adiposity of the extremity, particularly in the upper arm. If the AV fistula is located too deeply from the skin surface, a procedure can be performed to elevate the fistula, which has been reported to be very successful [<a href="#rid87">87</a>]. Alternatively, lipectomy or liposuction has also been proposed as a means to minimize the depth of AV fistulas in obese arms [<a href="#rid88">88-91</a>]. </p><p class="headingAnchor" id="H269443342"><span class="h2">Technical</span></p><p class="headingAnchor" id="H3794470592"><span class="h3">Surgical training and experience</span><span class="headingEndMark"> — </span>The training and experience of the surgeon available to create AV access varies and can affect the success of AV fistula creation [<a href="#rid18">18,92-97</a>]. </p><p>In a study designed to investigate whether intensity of surgical training influenced the type of vascular access placed and AV fistula survival, prospective data from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) were analyzed [<a href="#rid95">95</a>]. Significant predictors of AV fistula versus AV graft placement included number of AV fistulas placed and degree of emphasis on vascular access creation during training. In the United States, surgeons in training created fewer AV fistulas compared with those in other countries (mean 16 versus 39 [from 426 in other countries]) and noted less emphasis on vascular access placement compared with surgeons elsewhere. The risk of primary AV fistula failure was 34 percent lower when placed by surgeons who created &gt;25 (compared with &lt;25) AV fistulas during training. However, no difference was noted between categories of 25 to 75 or &gt;75 AV fistulas created during training. </p><p>Once out of training, surgeons' experience continues to vary in the number of AV fistulas they place, which in turn can impact the outcome of the procedure. As an example, in a United States study, the number of AV fistula or grafts placed by nearly 5000 surgeons ranged from 10 to 681 over a two-year period [<a href="#rid97">97</a>]. A successful outcome (ie, mature fistula) was more likely at six months follow-up for surgeons who performed &gt;85 AV fistula placements compared with those who performed fewer than 13 (odds ratio 1.5, 95% CI 1.4-1.6).</p><p class="headingAnchor" id="H3053713048"><span class="h3">Creating the AV fistula</span><span class="headingEndMark"> — </span>Related to training and experience is the appropriate choice of vessel and conduct of the procedure used to create the hemodialysis AV fistula. Perioperative factors that may lead to immediate issues following AV fistula creation are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1917.html" rel="external">"Arteriovenous fistula creation for hemodialysis and its complications"</a> and  <a class="medical medical_review" href="/z/d/html/96402.html" rel="external">"Primary failure of the hemodialysis arteriovenous fistula"</a>.)</p><p class="headingAnchor" id="H475107126"><span class="h2">Care and maintenance of the AV fistula</span><span class="headingEndMark"> — </span>Factors associated with the use, care, and maintenance of the AV fistula may contribute to AV fistula failure. These are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/112108.html" rel="external">"Overview of hemodialysis arteriovenous fistula maintenance and thrombosis prevention"</a> and  <a class="medical medical_review" href="/z/d/html/1957.html" rel="external">"Failure of the mature hemodialysis arteriovenous fistula"</a>.)</p><p class="headingAnchor" id="H890467200"><span class="h1">MULTIPLE RISK FACTORS</span><span class="headingEndMark"> — </span>As can be seen, there are a variety of risk factors that affect the success of an arteriovenous (AV) fistula. Most patients have more than one risk factor, and the burden increases with age. It is difficult for the clinician to determine the relative importance of these potential risk factors and to assess the effect of combinations when assessing the likelihood of achieving a functional AV fistula in the individual patient. While evaluating risk factors is important, risk stratification schemes have failed to accurately identify individuals in whom AV fistula placement is futile. While comorbid conditions affecting vascular access success become increasingly more common with age, they are not necessarily present [<a href="#rid98">98</a>]. Further, although potential demographic and clinical factors may be relevant, the most important determinant is the quality of the available vessels. Thus, no patient with end-stage kidney disease should be excluded from consideration for an AV fistula without vascular mapping and evaluation by an experienced hemodialysis vascular access surgeon. Decisions should be based on the individual patient status as determined by the clinical comorbidities that are present. </p><p>A study was conducted toward the development of an algorithm to be used in assessing individual patients having a combination of risk factors [<a href="#rid5">5</a>]. The goals of the study were to identify clinical characteristics that predicted failure of AV fistula maturation and to develop and validate a risk equation using these characteristics to stratify patients according to their risk. A clinical prediction rule was used to assign a prediction score ranging from 0 to 10.5. These scores were then used to define four risk categories: low risk (score &lt;2), moderate risk (score 2 to 3), high risk (score 3 to 7), and very high risk (score &gt;7). The algorithm was externally validated using 445 patients receiving a new AV fistula derived from five large dialysis centers. The four defined categories predicted the risk of failure to mature as 24, 34, 50, and 69 percent, respectively. The authors suggested that this scoring system could be used to guide the aggressiveness with which the individual patient is evaluated prior to dialysis access placement and postoperatively to detect failure maturation. As an example, in the low-risk patient, vascular mapping by physical examination only may be possible with routine postoperative monitoring, while the patient in the high-risk category might require angiographic evaluation (both vein and artery) and very close postoperative monitoring, anticipating the need for aggressive intervention to facilitate maturation.</p><p>In a later study, 195,756 incident adult dialysis patients with an AV fistula who had been followed for at least six months by nephrologists prior to initiation of dialysis were examined based upon the presence of risk factors for AV fistula failure of maturation [<a href="#rid45">45</a>]. The risk factors for AV fistula failure, determined by logistic regression, were substantially different from those predicted by the clinical prediction algorithm above. Based upon a comparison with the low-risk group, the likelihood of AV fistula use was 0.90 (95% CI 0.88-0.93) for the moderate-risk group, 0.80 (95% CI 0.78-0.83) for the high-risk group, and 0.68 (95% CI 0.63-0.73) for the very-high-risk group. </p><p>In assessing the importance of risk factors, it is important to realize that these two studies are based upon different patient populations [<a href="#rid5">5,45</a>]. The first proposed a scoring system to predict problems with AV fistula maturation and emphasizes the importance of using this data in presurgical selection and postsurgical management of individual patients [<a href="#rid5">5</a>]. The second study demonstrates actual prevalence of AV fistula utilization, the results, presumably, a reflection of presurgical selection and postsurgical management [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H2266334147"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112932.html" rel="external">"Society guideline links: Dialysis"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/132674.html" rel="external">"Society guideline links: Hemodialysis vascular access"</a>.)</p><p class="headingAnchor" id="H3771174719"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Recognition of risk factors, especially the presence of multiple risk factors, is important in planning arteriovenous (AV) access creation for hemodialysis. However, no patient with end-stage kidney disease should be excluded from consideration for an AV fistula without vascular mapping and evaluation by a dialysis-access-experienced surgeon. Individualization is critically important. (See <a class="local">'Use of risk factors'</a> above and <a class="local">'Multiple risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adverse hemodynamic characteristics (poor-quality vessels) are the most important factors contributing to failure of AV fistula maturation and subsequent failure of a mature AV fistula. Demographic and clinical factors increase the risk of AV fistula failure primarily only when they affect hemodynamics. Although patients with poor-quality vessels are not ideal candidates for an AV fistula initially, a secondary fistula may be possible after a period of AV graft use, if the AV graft becomes problematic. (See <a class="local">'Hemodynamic'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Older age is a risk factor for decreased life expectancy on dialysis, but age is largely a surrogate for an increasing burden of comorbid conditions (particularly diabetes and cardiovascular disease). The presence of comorbidities more strongly influences survival compared with age alone. (See <a class="local">'Age'</a> above and <a class="local">'Clinical comorbidities'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Female sex is a risk factor for failure of AV fistula maturation and subsequent failure of the mature AV fistula. The reasons for sex-related differences are not clear. While it has been suggested that females have smaller vessels, diameter differences have not been consistently related to unsuccessful AV fistulas. (See <a class="local">'Sex'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Race and ethnicity have been identified as significant risk factors for failure of AV fistula maturation. The reasons for the difference are not totally clear but may be related to differences in comorbidities between the groups. (See <a class="local">'Race/ethnicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical comorbidities (cardiac disease, peripheral arterial disease, pulmonary disease, diabetes mellitus, obesity) adversely affect the placement and clinical success of AV fistulas. These generally exert their effect by adversely affecting hemodynamics. (See <a class="local">'Clinical comorbidities'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other factors that may affect the outcomes of AV fistula creation include the experience of the surgeon and other technical issues in creating, using, and caring for the fistula. (See <a class="local">'Technical'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lok CE, Huber TS, Lee T, et al. KDOQI Vascular Access Guidelines Work Group. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75:S1.</a></li><li><a class="nounderline abstract_t">Chang VT, Hwang SS, Feuerman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 2000; 88:1175.</a></li><li><a class="nounderline abstract_t">Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005; 16:2487.</a></li><li><a class="nounderline abstract_t">Crail S, Walker R, Brown M, Renal Supportive Care working group. Renal supportive and palliative care: position statement. Nephrology (Carlton) 2013; 18:393.</a></li><li><a class="nounderline abstract_t">Lok CE, Allon M, Moist L, et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17:3204.</a></li><li><a class="nounderline abstract_t">Salman L, Alex M, Unger SW, et al. Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective study. J Am Coll Surg 2009; 209:100.</a></li><li><a class="nounderline abstract_t">Vachharajani TJ, Moossavi S, Jordan JR, et al. Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol 2011; 6:1663.</a></li><li><a class="nounderline abstract_t">Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007; 146:177.</a></li><li><a class="nounderline abstract_t">Foote C, Ninomiya T, Gallagher M, et al. Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transplant 2012; 27:3581.</a></li><li><a class="nounderline abstract_t">Couchoud C, Labeeuw M, Moranne O, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24:1553.</a></li><li><a class="nounderline abstract_t">Lee T, Thamer M, Zhang Y, et al. Outcomes of Elderly Patients after Predialysis Vascular Access Creation. J Am Soc Nephrol 2015; 26:3133.</a></li><li><a class="nounderline abstract_t">O'Hare AM, Bertenthal D, Walter LC, et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007; 71:555.</a></li><li><a class="nounderline abstract_t">Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg 2007; 45:420.</a></li><li class="breakAll">United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016. https://www.usrds.org/2016/view/Default.aspx (Accessed on August 08, 2017).</li><li><a class="nounderline abstract_t">Richardson AI 2nd, Leake A, Schmieder GC, et al. Should fistulas really be first in the elderly patient? J Vasc Access 2009; 10:199.</a></li><li><a class="nounderline abstract_t">Lok CE, Oliver MJ, Su J, et al. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int 2005; 67:2462.</a></li><li><a class="nounderline abstract_t">Jennings WC, Landis L, Taubman KE, Parker DE. Creating functional autogenous vascular access in older patients. J Vasc Surg 2011; 53:713.</a></li><li><a class="nounderline abstract_t">O'Hare AM, Dudley RA, Hynes DM, et al. Impact of surgeon and surgical center characteristics on choice of permanent vascular access. Kidney Int 2003; 64:681.</a></li><li><a class="nounderline abstract_t">Beaulieu MC, Dumaine CS, Romann A, Kiaii M. Advanced age is not a barrier to creating a functional arteriovenous fistula: a retrospective study. J Vasc Access 2017; 18:307.</a></li><li><a class="nounderline abstract_t">Rooijens PP, Tordoir JH, Stijnen T, et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004; 28:583.</a></li><li><a class="nounderline abstract_t">Weale AR, Bevis P, Neary WD, et al. Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly. J Vasc Surg 2008; 47:144.</a></li><li><a class="nounderline abstract_t">Pounds LL, Teodorescu VJ. Chronic kidney disease and dialysis access in women. J Vasc Surg 2013; 57:49S.</a></li><li><a class="nounderline abstract_t">Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11:319.</a></li><li><a class="nounderline abstract_t">Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med 2008; 5 Suppl A:S3.</a></li><li><a class="nounderline abstract_t">Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003; 10:3.</a></li><li><a class="nounderline abstract_t">Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52:661.</a></li><li><a class="nounderline abstract_t">Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69:375.</a></li><li><a class="nounderline abstract_t">Puskar D, Pasini J, Savić I, et al. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis. Croat Med J 2002; 43:306.</a></li><li><a class="nounderline abstract_t">Obialo CI, Tagoe AT, Martin PC, Asche-Crowe PE. Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients. ASAIO J 2003; 49:435.</a></li><li><a class="nounderline abstract_t">Peterson WJ, Barker J, Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol 2008; 3:437.</a></li><li><a class="nounderline abstract_t">Marcus RJ, Marcus DA, Sureshkumar KK, et al. Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome. Gend Med 2007; 4:193.</a></li><li><a class="nounderline abstract_t">Caplin N, Sedlacek M, Teodorescu V, et al. Venous access: women are equal. Am J Kidney Dis 2003; 41:429.</a></li><li><a class="nounderline abstract_t">Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63:346.</a></li><li><a class="nounderline abstract_t">Xue JL, Eggers PW, Agodoa LY, et al. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 2007; 18:1299.</a></li><li><a class="nounderline abstract_t">Agodoa L, Eggers P. Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial 2007; 20:577.</a></li><li><a class="nounderline abstract_t">Ricks J, Molnar MZ, Kovesdy CP, et al. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis 2011; 58:574.</a></li><li><a class="nounderline abstract_t">Murthy BV, Molony DA, Stack AG. Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol 2005; 16:782.</a></li><li><a class="nounderline abstract_t">Lopes AA. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure. Adv Ren Replace Ther 2004; 11:14.</a></li><li><a class="nounderline abstract_t">Glanton CW, Hypolite IO, Hshieh PB, et al. Factors associated with improved short term survival in obese end stage renal disease patients. Ann Epidemiol 2003; 13:136.</a></li><li><a class="nounderline abstract_t">Liao Y, Bang D, Cosgrove S, et al. Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009. MMWR Surveill Summ 2011; 60:1.</a></li><li><a class="nounderline abstract_t">Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56:275.</a></li><li><a class="nounderline abstract_t">Wilmink T, Wijewardane A, Lee K, et al. Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital. Clin Kidney J 2017; 10:62.</a></li><li><a class="nounderline abstract_t">Gibson KD, Caps MT, Kohler TR, et al. Assessment of a policy to reduce placement of prosthetic hemodialysis access. Kidney Int 2001; 59:2335.</a></li><li><a class="nounderline abstract_t">Woo K, Gascue L, Goldman DP, Romley JA. Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly. J Vasc Surg 2017; 65:783.</a></li><li><a class="nounderline abstract_t">Lilly MP, Lynch JR, Wish JB, et al. Prevalence of arteriovenous fistulas in incident hemodialysis patients: correlation with patient factors that may be associated with maturation failure. Am J Kidney Dis 2012; 59:541.</a></li><li><a class="nounderline abstract_t">de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302:1782.</a></li><li><a class="nounderline abstract_t">Husain-Syed F, McCullough PA, Birk HW, et al. Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach. J Am Coll Cardiol 2015; 65:2433.</a></li><li><a class="nounderline abstract_t">Wasse H, Singapuri MS. High-output heart failure: how to define it, when to treat it, and how to treat it. Semin Nephrol 2012; 32:551.</a></li><li><a class="nounderline abstract_t">Martínez-Gallardo R, Ferreira-Morong F, García-Pino G, et al. Congestive heart failure in patients with advanced chronic kidney disease: association with pre-emptive vascular access placement. Nefrologia 2012; 32:206.</a></li><li><a class="nounderline abstract_t">Korsheed S, Eldehni MT, John SG, et al. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 2011; 26:3296.</a></li><li><a class="nounderline abstract_t">Amerling R, Ronco C, Kuhlman M, Winchester JF. Arteriovenous fistula toxicity. Blood Purif 2011; 31:113.</a></li><li><a class="nounderline abstract_t">Basile C, Lomonte C, Vernaglione L, et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 2008; 23:282.</a></li><li><a class="nounderline abstract_t">Dixon BS. Why don't fistulas mature? Kidney Int 2006; 70:1413.</a></li><li><a class="nounderline abstract_t">Zarins CK, Zatina MA, Giddens DP, et al. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg 1987; 5:413.</a></li><li><a class="nounderline abstract_t">Woods JD, Turenne MN, Strawderman RL, et al. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 1997; 30:50.</a></li><li><a class="nounderline abstract_t">Chitalia N, Ross L, Krishnamoorthy M, et al. Neointimal hyperplasia and calcification in medium sized arteries in adult patients with chronic kidney disease. Semin Dial 2015; 28:E35.</a></li><li><a class="nounderline abstract_t">Kim YO, Song HC, Yoon SA, et al. Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients. Am J Kidney Dis 2003; 41:422.</a></li><li><a class="nounderline abstract_t">Georgiadis GS, Georgakarakos EI, Antoniou GA, et al. Correlation of pre-existing radial artery macrocalcifications with late patency of primary radiocephalic fistulas in diabetic hemodialysis patients. J Vasc Surg 2014; 60:462.</a></li><li><a class="nounderline abstract_t">Allon M, Litovsky S, Young CJ, et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis 2011; 58:437.</a></li><li><a class="nounderline abstract_t">Malovrh M. Non-invasive evaluation of vessels by duplex sonography prior to construction of arteriovenous fistulas for haemodialysis. Nephrol Dial Transplant 1998; 13:125.</a></li><li><a class="nounderline abstract_t">Malovrh M. Native arteriovenous fistula: preoperative evaluation. Am J Kidney Dis 2002; 39:1218.</a></li><li><a class="nounderline abstract_t">Wall LP, Gasparis A, Callahan S, et al. Impaired hyperemic response is predictive of early access failure. Ann Vasc Surg 2004; 18:167.</a></li><li><a class="nounderline abstract_t">Lockhart ME, Robbin ML, Allon M. Preoperative sonographic radial artery evaluation and correlation with subsequent radiocephalic fistula outcome. J Ultrasound Med 2004; 23:161.</a></li><li><a class="nounderline abstract_t">Chiang WC, Lin SL, Tsai TJ, Hsieh BS. High resistive index of the radial artery is related to early primary radiocephalic hemodialysis fistula failure. Clin Nephrol 2001; 56:236.</a></li><li><a class="nounderline abstract_t">Gibyeli Genek D, Tuncer Altay C, Unek T, et al. Can primary failure of arteriovenous fistulas be anticipated? Hemodial Int 2015; 19:296.</a></li><li><a class="nounderline abstract_t">Yigla M, Nakhoul F, Sabag A, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123:1577.</a></li><li><a class="nounderline abstract_t">Acarturk G, Albayrak R, Melek M, et al. The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients. Int Urol Nephrol 2008; 40:509.</a></li><li><a class="nounderline abstract_t">Alkhouli M, Sandhu P, Boobes K, et al. Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease. Nefrologia 2015; 35:234.</a></li><li><a class="nounderline abstract_t">Reque J, Garcia-Prieto A, Linares T, et al. Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol 2017; 45:107.</a></li><li><a class="nounderline abstract_t">Wheaton AG, Cunningham TJ, Ford ES, et al. Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:289.</a></li><li><a class="nounderline abstract_t">Ford ES, Croft JB, Mannino DM, et al. COPD surveillance--United States, 1999-2011. Chest 2013; 144:284.</a></li><li><a class="nounderline abstract_t">Ford ES, Mannino DM, Wheaton AG, et al. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013; 143:1395.</a></li><li><a class="nounderline abstract_t">Beks PJ, Mackaay AJ, de Neeling JN, et al. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995; 38:86.</a></li><li><a class="nounderline abstract_t">Konner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant 2000; 15:1317.</a></li><li><a class="nounderline abstract_t">Ravani P, Marcelli D, Malberti F. Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistulas for hemodialysis. Am J Kidney Dis 2002; 40:1264.</a></li><li><a class="nounderline abstract_t">Diehm N, van den Berg JC, Schnyder V, et al. Determinants of haemodialysis access survival. Vasa 2010; 39:133.</a></li><li><a class="nounderline abstract_t">Allon M, Ornt DB, Schwab SJ, et al. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group. Kidney Int 2000; 58:2178.</a></li><li><a class="nounderline abstract_t">Lin SL, Huang CH, Chen HS, et al. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol 1998; 18:96.</a></li><li><a class="nounderline abstract_t">Sedlacek M, Teodorescu V, Falk A, et al. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J Kidney Dis 2001; 38:560.</a></li><li><a class="nounderline abstract_t">Field M, MacNamara K, Bailey G, et al. Primary patency rates of AV fistulas and the effect of patient variables. J Vasc Access 2008; 9:45.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81:543.</a></li><li><a class="nounderline abstract_t">Stolic R. Obesity in renal failure--health or disease? Med Hypotheses 2010; 75:497.</a></li><li><a class="nounderline abstract_t">Park J, Ahmadi SF, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 2014; 56:415.</a></li><li><a class="nounderline abstract_t">Chan MR, Young HN, Becker YT, Yevzlin AS. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study. Semin Dial 2008; 21:274.</a></li><li><a class="nounderline abstract_t">Kats M, Hawxby AM, Barker J, Allon M. Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int 2007; 71:39.</a></li><li><a class="nounderline abstract_t">Plumb TJ, Adelson AB, Groggel GC, et al. Obesity and hemodialysis vascular access failure. Am J Kidney Dis 2007; 50:450.</a></li><li><a class="nounderline abstract_t">Singh P, Robbin ML, Lockhart ME, Allon M. Clinically immature arteriovenous hemodialysis fistulas: effect of US on salvage. Radiology 2008; 246:299.</a></li><li><a class="nounderline abstract_t">Bourquelot P, Tawakol JB, Gaudric J, et al. Lipectomy as a new approach to secondary procedure superficialization of direct autogenous forearm radial-cephalic arteriovenous accesses for hemodialysis. J Vasc Surg 2009; 50:369.</a></li><li><a class="nounderline abstract_t">Krochmal DJ, Rebecca AM, Kalkbrenner KA, et al. Superficialization of deep arteriovenous access procedures in obese patients using suction-assisted lipectomy: A novel approach. Can J Plast Surg 2010; 18:25.</a></li><li><a class="nounderline abstract_t">Roberts C. Saving a brachiocephalic fistula using lipectomy. Nephrol Nurs J 2005; 32:331.</a></li><li><a class="nounderline abstract_t">Barnard KJ, Taubman KE, Jennings WC. Accessible autogenous vascular access for hemodialysis in obese individuals using lipectomy. Am J Surg 2010; 200:798.</a></li><li><a class="nounderline abstract_t">He C, Charoenkul V, Kahn T, et al. Impact of the surgeon on the prevalence of arteriovenous fistulas. ASAIO J 2002; 48:39.</a></li><li><a class="nounderline abstract_t">Choi KL, Salman L, Krishnamurthy G, et al. Impact of surgeon selection on access placement and survival following preoperative mapping in the "Fistula First" era. Semin Dial 2008; 21:341.</a></li><li><a class="nounderline abstract_t">Huijbregts HJ, Bots ML, Moll FL, et al. Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas. J Vasc Surg 2007; 45:962.</a></li><li><a class="nounderline abstract_t">Saran R, Elder SJ, Goodkin DA, et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg 2008; 247:885.</a></li><li><a class="nounderline abstract_t">Goodkin DA, Pisoni RL, Locatelli F, et al. Hemodialysis vascular access training and practices are key to improved access outcomes. Am J Kidney Dis 2010; 56:1032.</a></li><li><a class="nounderline abstract_t">Shahinian VB, Zhang X, Tilea AM, et al. Surgeon Characteristics and Dialysis Vascular Access Outcomes in the United States: A Retrospective Cohort Study. Am J Kidney Dis 2020; 75:158.</a></li><li><a class="nounderline abstract_t">Davidson I, Gallieni M. Optimizing vascular access in the elderly: words we use affect patient care. J Vasc Access 2015; 16:437.</a></li></ol></div><div id="topicVersionRevision">Topic 113929 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : KDOQI Vascular Access Guidelines Work Group. KDOQI clinical practice guideline for vascular access: 2019 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10699909" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15975996" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23574050" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Renal supportive and palliative care: position statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16988062" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19651069" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Secondary autogenous arteriovenous fistulas in the "fistula first" era: results of a longterm prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21685023" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17283348" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Octogenarians and nonagenarians starting dialysis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22565061" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Survival of elderly dialysis patients is predicted by both patient and practice characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19096087" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25855782" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Outcomes of Elderly Patients after Predialysis Vascular Access Creation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17245396" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17264030" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A meta-analysis of dialysis access outcome in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17264030" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A meta-analysis of dialysis access outcome in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19670174" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Should fistulas really be first in the elderly patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15882293" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Arteriovenous fistula outcomes in the era of the elderly dialysis population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21129897" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Creating functional autogenous vascular access in older patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12846766" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Impact of surgeon and surgical center characteristics on choice of permanent vascular access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28478636" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Advanced age is not a barrier to creating a functional arteriovenous fistula: a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15531191" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18178467" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23522719" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Chronic kidney disease and dialysis access in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10665939" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18395681" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gender and human chronic renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12616458" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The role of gender in the progression of renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18805347" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16408129" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12035137" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12918587" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Adequacy and survival of autogenous arteriovenous fistula in African American hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18235150" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Disparities in fistula maturation persist despite preoperative vascular mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18022587" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12552506" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Venous access: women are equal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472802" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17329578" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17991208" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21658829" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15677309" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14730535" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12559673" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Factors associated with improved short term survival in obese end stage renal disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21597458" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10411703" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28638605" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11380838" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Assessment of a policy to reduce placement of prosthetic hemodialysis access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28027805" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Variations in outcomes of hemodialysis vascular access by race/ethnicity in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22342212" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prevalence of arteriovenous fistulas in incident hemodialysis patients: correlation with patient factors that may be associated with maturation failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19861670" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Cardiovascular and noncardiovascular mortality among patients starting dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26046738" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23217335" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : High-output heart failure: how to define it, when to treat it, and how to treat it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22425802" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Congestive heart failure in patients with advanced chronic kidney disease: association with pre-emptive vascular access placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21317408" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21228578" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Arteriovenous fistula toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17942475" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16883317" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Why don't fistulas mature?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3509594" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Shear stress regulation of artery lumen diameter in experimental atherogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9214401" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Vascular access survival among incident hemodialysis patients in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25488635" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Neointimal hyperplasia and calcification in medium sized arteries in adult patients with chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12552505" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24680240" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Correlation of pre-existing radial artery macrocalcifications with late patency of primary radiocephalic fistulas in diabetic hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21719173" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9481727" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Non-invasive evaluation of vessels by duplex sonography prior to construction of arteriovenous fistulas for haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12046034" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Native arteriovenous fistula: preoperative evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15253251" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Impaired hyperemic response is predictive of early access failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14992353" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Preoperative sonographic radial artery evaluation and correlation with subsequent radiocephalic fistula outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11597039" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : High resistive index of the radial artery is related to early primary radiocephalic hemodialysis fistula failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25170532" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Can primary failure of arteriovenous fistulas be anticipated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12740276" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pulmonary hypertension in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17985208" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26299166" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cardiac complications of arteriovenous fistulas in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27941345" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25811677" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Employment and activity limitations among adults with chronic obstructive pulmonary disease--United States, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23619732" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : COPD surveillance--United States, 1999-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23715520" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7744233" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10978385" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Primary vascular access in diabetic patients: an audit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12460046" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Vascular access surgery managed by renal physicians: the choice of native arteriovenous fistulas for hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20464668" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Determinants of haemodialysis access survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11044239" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9569949" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11532689" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18379980" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Primary patency rates of AV fistulas and the effect of patient variables.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15755821" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Survival advantages of obesity in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20656410" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Obesity in renal failure--health or disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24438733" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Obesity paradox in end-stage kidney disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18397205" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17003811" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Impact of obesity on arteriovenous fistula outcomes in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17720524" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Obesity and hemodialysis vascular access failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17991787" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Clinically immature arteriovenous hemodialysis fistulas: effect of US on salvage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19631871" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Lipectomy as a new approach to secondary procedure superficialization of direct autogenous forearm radial-cephalic arteriovenous accesses for hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21358871" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Superficialization of deep arteriovenous access procedures in obese patients using suction-assisted lipectomy: A novel approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16035473" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Saving a brachiocephalic fistula using lipectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21146023" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Accessible autogenous vascular access for hemodialysis in obese individuals using lipectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11814096" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Impact of the surgeon on the prevalence of arteriovenous fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18564969" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Impact of surgeon selection on access placement and survival following preoperative mapping in the "Fistula First" era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17466788" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18438128" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20961676" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Hemodialysis vascular access training and practices are key to improved access outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31585684" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Surgeon Characteristics and Dialysis Vascular Access Outcomes in the United States: A Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26349884" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Optimizing vascular access in the elderly: words we use affect patient care.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
